Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease

Alzheimer's Research & Therapy
Sanka AmadoruChristopher C Rowe

Abstract

The Centiloid scale was developed to standardise the results of beta-amyloid (Aβ) PET. We aimed to determine the Centiloid unit (CL) thresholds for CERAD sparse and moderate-density neuritic plaques, Alzheimer's disease neuropathologic change (ADNC) score of intermediate or high probability of Alzheimer's Disease (AD), final clinicopathological diagnosis of AD, and expert visual read of a positive Aβ PET scan. Aβ PET results in CL for 49 subjects were compared with post-mortem findings, visual read, and final clinicopathological diagnosis. The Youden Index was used to determine the optimal CL thresholds from receiver operator characteristic (ROC) curves. A threshold of 20.1 CL (21.3 CL when corrected for time to death, AUC 0.97) yielded highest accuracy in detecting moderate or frequent plaque density while < 10 CL was optimal for excluding neuritic plaque. The threshold for ADNC intermediate or high likelihood AD was 49.4 CL (AUC 0.98). Those cases with a final clinicopathological diagnosis of AD yielded a median CL result of 87.7 (IQR ± 42.2) with 94% > 45 CL. Positive visual read agreed highly with results > 26 CL. Centiloid values < 10 accurately reflected the absence of any neuritic plaque and > 20 CL indicated the presenc...Continue Reading

References

Jun 8, 2001·The American Journal of Pathology·D M MannUNKNOWN Members of the Familial Alzheimer's Disease Pathology Study Group
Jun 8, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William E KlunkSteven T DeKosky
Apr 26, 2008·Biometrical Journal. Biometrische Zeitschrift·Marcus D RuoppEnrique F Schisterman
Sep 16, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Christopher C Rowe, Victor L Villemagne
Jan 24, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Bradley T HymanThomas J Montine
Jul 7, 2012·Journal of Alzheimer's Disease : JAD·Tina L BeckettM Paul Murphy
Jan 31, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Keith A JohnsonUNKNOWN Amyloid Imaging Taskforce
Feb 12, 2013·Journal of Nuclear Medicine Technology·Christopher C Rowe, Victor L Villemagne
Mar 13, 2013·Lancet Neurology·Victor L VillemagneUNKNOWN Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group
Apr 12, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Christopher C RoweVictor L Villemagne
Jan 16, 2014·PloS One·Luping ZhouUNKNOWN AIBL Research Group
Mar 13, 2014·Molecular Psychiatry·P M DoraiswamyUNKNOWN AV45-A11 Study Group
May 23, 2014·Lancet Neurology·Bruno DuboisJeffrey L Cummings
Aug 26, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Lennart ThurfjellPaul Sherwin
Sep 27, 2014·Neurobiology of Aging·Pierrick BourgeatUNKNOWN AIBL Research Group
Dec 3, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·William E KlunkMark A Mintun
Mar 6, 2015·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·Osama SabriHenryk Barthel
Apr 1, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Osama SabriUNKNOWN Florbetaben Phase 3 Study Group
Feb 26, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Christopher C RoweVictor L Villemagne
Jul 13, 2016·Brain : a Journal of Neurology·Antoine LeuzyAgneta Nordberg
Jun 24, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Christopher C RoweVictor L Villemagne
Jun 28, 2017·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Rachel H TanGlenda M Halliday
Apr 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackUNKNOWN Contributors
Jul 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael NavitskyMichael D Devous
Aug 22, 2018·NeuroImage·Pierrick BourgeatUNKNOWN AIBL research group
Oct 23, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Renaud La JoieGil D Rabinovici
May 19, 2019·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Vincent DoréSusan De Santi

❮ Previous
Next ❯

Citations

Sep 29, 2020·Journal of Alzheimer's Disease : JAD·Ying XiaUNKNOWN AIBL Research Group
Nov 29, 2020·NeuroImage·Pierrick BourgeatUNKNOWN AIBL research group
Jan 27, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Vincent DoréChristopher C Rowe
Jan 24, 2021·Seminars in Nuclear Medicine·Natasha KrishnadasChristopher C Rowe
Feb 23, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Lyduine E CollijUNKNOWN AMYPAD consortium
Apr 3, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Jordi PeguerolesUNKNOWN Australian Imaging, Biomarkers and Lifestyle Research Group
Apr 9, 2021·Alzheimer's Research & Therapy·Jolien M SchaeverbekeRik Vandenberghe
Jun 1, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Claire E SextonMaria C Carrillo
May 25, 2021·Frontiers in Aging Neuroscience·Weiqi BaoYiyun Henry Huang
Mar 14, 2021·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Gérard N BischofAlexander Drzezga
Jul 29, 2021·Alzheimer's Research & Therapy·Marta Milà-AlomàUNKNOWN ALFA study
Oct 7, 2021·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Giordana Salvi de SouzaAna Maria Marques da Silva
Sep 18, 2021·Brain : a Journal of Neurology·Mariska ReinartzRik Vandenberghe

❮ Previous
Next ❯

Software Mentioned

SPM8
SoT
CapAIBL
Florbetaben
MedView

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

Alzheimer's Research & Therapy
Gemma SalvadóAlzheimer’s Disease Neuroimaging Initiative, for the ALFA Study
European Journal of Nuclear Medicine and Molecular Imaging
Christopher C RoweVictor L Villemagne
© 2021 Meta ULC. All rights reserved